Collaboration gives Magellan Rx customers a first-of-its-kind solution to address the complexities of precision medicine PHOENIX & BURLINGTON, Mass. --(BUSINESS WIRE)--Apr. 8, 2021-- Magellan Rx Management , a division of Magellan Health, Inc . (NASDAQ: MGLN), and Trapelo Health , today announced

PHOENIX --(BUSINESS WIRE)--Mar. 31, 2021-- Magellan Healthcare , the behavioral and specialty healthcare segment of Magellan Health, Inc. (NASDAQ: MGLN), today announced resources and programs to educate and support individuals in recognition of Autism Awareness Month throughout April.

PHOENIX --(BUSINESS WIRE)--Mar. 18, 2021-- Magellan Health, Inc . (NASDAQ: MGLN) today announced that its subsidiary Magellan Federal has been selected to once again serve as a contractor for the Military and Family Life Counseling (MFLC) program, which provides counseling for adults and children

PHOENIX --(BUSINESS WIRE)--Feb. 26, 2021-- Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and the year ended December 31, 2020 , as summarized below:   Three Months Ended Twelve Months Ended December 31 December 31 (In millions, except per share

PHOENIX --(BUSINESS WIRE)--Feb. 16, 2021-- Magellan Health, Inc . (NASDAQ: MGLN) today announced that Magellan Rx Management (MRx), the pharmacy benefit management division of the company, has achieved 5 Stars from the Centers for Medicare & Medicaid Services (CMS) for its Statin Use in Persons

Behavioral economics program to improve medication adherence and health outcomes PHOENIX --(BUSINESS WIRE)--Feb. 10, 2021-- Magellan Rx Management , the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN), announced today the implementation of a pilot to

Guidelines based on clinical research and serve as a comprehensive resource PHOENIX --(BUSINESS WIRE)--Feb. 9, 2021-- Magellan Healthcare , the behavioral and specialty healthcare segment of Magellan Health, Inc . (NASDAQ: MGLN), published its updated clinical monograph, Understanding and Meeting

Health plans are making the switch to lower-cost biosimilars while maintaining high-quality of care for members Program success based on proactive, high-touch engagement with provider community, as measured by new-start prior authorizations of oncology biosimilar compared to reference product

PHOENIX --(BUSINESS WIRE)--Jan. 28, 2021-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Magellan Medicaid Administration, Inc. (MMA), Magellan Rx Management’s Government Pharmacy Benefit Management (PBM) division, has earned ISO 9001:2015 certification for the design and delivery of

- Acquisition will broaden and deepen Centene's whole health capabilities, while establishing a leading behavioral health platform at a critical time - Combined platform to deliver better health outcomes for complex populations through the integration of physical and mental health care - Important